Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
137.44
+7.82 (6.03%)
Nov 28, 2025, 1:00 PM EST - Market closed

Belite Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
4,7951,9481,263750--
Market Cap Growth
91.37%54.32%68.44%---
Enterprise Value
4,6511,8611,221701--
Last Close Price
137.4463.1045.7530.14--
PB Ratio
17.5013.3613.9618.06--
P/TBV Ratio
17.5013.3713.9618.06--
Debt / Equity Ratio
-0.000.010.02--
Quick Ratio
-24.0924.5020.0110.6126.36
Current Ratio
33.3524.3124.7620.3510.6626.41
Return on Equity (ROE)
-32.30%-30.60%-47.95%-43.45%-46.60%-
Return on Assets (ROA)
-21.22%-20.26%-28.50%-25.59%-27.78%-
Return on Capital (ROIC)
-21.87%-21.04%-29.61%-27.13%-29.52%-
Return on Capital Employed (ROCE)
-24.70%-27.40%-34.80%-30.40%-58.60%-23.20%
Earnings Yield
-1.30%-1.85%-2.50%-1.69%--
FCF Yield
--1.51%-2.37%-1.58%--
Buyback Yield / Dilution
-8.68%-14.83%-33.12%-108.74%-8.87%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q